Key Financial Figures

Policyholders' Account (₹ in Lakh):

  • Gross Premium Income: ₹204,752 (Q1 FY2027) vs ₹306,066 (Q4 FY2026) vs ₹165,343 (Q1 FY2026)
  • First Year Premium: ₹46,606
  • Renewal Premium: ₹111,738
  • Single Premium: ₹57,762
  • Income from Investments (Net): ₹226,879
  • Other Income: ₹659
  • Transfer from Shareholders' Account: ₹2,408
  • Total Income: ₹434,698
  • Net Commission: ₹11,718
  • Expenses of Management: ₹44,721
  • Benefits Paid (Net): ₹83,466
  • Change in Actuarial Liability: ₹299,731
  • Surplus/(Deficit): ₹6,780

Shareholders' Account (₹ in Lakh):

  • Transfer from Policyholders' Account: ₹2,734
  • Investment Income (Net): ₹2,932
  • Other Income: ₹133
  • Profit before tax: ₹3,151
  • Provision for tax: ₹337
  • Profit after tax: ₹2,814
  • Profit carried to Balance Sheet: ₹55,861
  • Paid-up equity share capital: ₹95,000 (95,000 shares of ₹10 each)
  • Reserves and Surplus: ₹68,361

Analytical Ratios:

  • Solvency Ratio: 198% (Q1 FY2027) vs 190% (Q4 FY2026) vs 200% (Q1 FY2026)
  • Expenses of Management Ratio: 20.7% vs 18.6% vs 19.6%
  • Policyholder's liabilities to shareholders' fund: 2946.4%
  • Basic EPS: ₹0.30 (not annualized)
  • Diluted EPS: ₹0.30 (not annualized)

Balance Sheet Position (as at June 30, 2026, ₹ in Lakh):

  • Total Assets: ₹5,001,595
  • Shareholders' Funds: ₹163,361
  • Borrowings: ₹25,000
  • Policyholders' Funds: ₹4,737,220
  • Investments:
  • Shareholders: ₹189,061
  • Policyholders: ₹2,814,941
  • Assets held to cover linked liabilities: ₹1,964,313

Segment Reporting:

The company operates across multiple segments including Linked Non-Participating (Life, Pension, Health, Others), Non-Linked Participating (Life, Pension, Health, Others), and Non-Linked Non-Participating (Life, Pension, Health, Others). Significant segments include:

  • Non-Linked Non-Participating - Life: Net Premium ₹93,236, Income from Investments ₹29,760
  • Non-Linked Non-Participating - Pension: Net Premium ₹20,928, Income from Investments ₹5,451
  • Linked Non-Participating - Life: Segment surplus ₹2,734

Audit and Review Details

  • Joint statutory auditors M/s Brahmayya & Co. (Firm Reg. No. 000513S) and M/s Raj Har Gopal & Co. (Firm Reg. No. 002074N) issued limited review report without any observations
  • Actuarial valuation certified by Appointed Actuary in accordance with IRDAI guidelines

Special Notes

  • IRDAI granted forbearance permitting deferral of Ind AS adoption for one year (Note 7)
  • Company continues with Indian GAAP and Schedule II of IRDAI Regulations, 2024
  • 100% provision on CPs and NCDs of IL&FS and IL&FS Financial Services Ltd due to default
  • No investor complaints pending at beginning or received during the quarter
  • No subsidiaries/associates/joint ventures - consolidated financial statements not applicable
  • Previous period figures have been re-grouped for consistency

Dates and Timelines

  • Board Meeting: 20th July 2026
  • Quarter Ended: 30th June 2026
  • Financial results to be published on company website by 14th August 2026